/
USNA
$21.01+$0.31 (+1.50%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$382.2M
18M shares
52-week range
$16.60 – $38.32
20% from low
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange
NYSE
CS
Borrow rate
0.37%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-81.72
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.19B | $1.06B | $1.13B | $1.19B | $998.6M | $921.0M | $854.5M | $925.3M |
| Cost of revenue | $217.4M | $202.0M | $222.9M | $230.9M | $207.3M | $189.4M | $175.8M | $200.9M |
| Gross profit | $971.8M | $858.9M | $911.8M | $955.5M | $791.3M | $731.6M | $678.8M | $724.4M |
| Gross margin | 81.7% | 81.0% | 80.4% | 80.5% | 79.2% | 79.4% | 79.4% | 78.3% |
| R&D | $10.2M | $10.3M | $10.6M | $11.1M | $11.6M | $11.4M | $11.6M | $0 |
| Operating income | $188.4M | $146.2M | $176.5M | $170.2M | $107.6M | $93.1M | $66.3M | $50.9M |
| EBITDA | $188.4M | $169.0M | $201.0M | $192.9M | $130.2M | $123.1M | $98.9M | $82.1M |
| Net income | $126.2M | $100.5M | $124.7M | $116.5M | $69.3M | $63.8M | $42.0M | $10.8M |
| Net margin | 10.6% | 9.5% | 11.0% | 9.8% | 6.9% | 6.9% | 4.9% | 1.2% |
| EPS (diluted) | 5.12 | 4.41 | 5.86 | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $945M | $2.12 | $2.12–$2.12 | 1 |
| 2028 | $1.0B | $2.77 | $2.77–$2.77 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$92.04
Price
$21.01
Implied upside
+338%
Peer comparison
USANA Health Sciences Inc
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
www.usana.com- Employees
- 1,570
- IPO / List date
- Apr 22, 1993
- HQ
- SALT LAKE CITY, UT
Held by traders on TradeandTell
No one on the platform currently holds USNA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,017,630 | $17.8M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2016-11-22 | 2-for-1 |
| 2003-10-23 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded USNA yet.
